ALPI and myeloid sarcoma: The present study demonstrates for the first time that sex-dependent effects on the gut microbiome mediate sexual dimorphism in MS in C57BL/6 mice and sex-specific expression and activity of IAP, a major gut microbiota-modifying factor [31–33].